Partial NMDA receptor antagonism with ketamine could, therefore, attenuate this pathological glutamatergic drive, shift transmission toward AMPA-mediated pathways, enhance BDNF-dependent synaptogenesis, and facilitate functional reorganization of post-stroke networks. This evidence concerns the gene BDNF and Stroke.